Sunitinib Malate in Patients With Non-Clear Cell Renal Cell Cancer
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn the effectiveness of Sutent® (sunitinib
malate, SU011248) in the treatment of patients with non-clear cell renal cell cancer. The
safety of sunitinib malate will also be studied.